Porous carriers for controlled/modulated drug delivery

Indian Journal of Pharmaceutical Sciences

Volumn 71, Issue 6, 2009, Pages 599-607

  Ahuja, G ^a   Pathak, K ^a  

^a Rajiv Academy for Pharmacy ^*  (India)

Author keywords

Adsorbents; Adsorption; Controlled delivery; Porosity; Porous carriers

Indexed keywords

ADSORBENT; ALENDRONIC ACID; AMPICILLIN; BENZOIC ACID; BRILLIANT BLUE; DEXAMETHASONE; DILTIAZEM; DRUG CARRIER; ETHYLENE VINYL ACETATE COPOLYMER; FENOFIBRATE; GENTAMICIN; HEMOGLOBIN; IBUPROFEN; INDOMETACIN; KETOPROFEN; LORATADINE; LOW MOLECULAR WEIGHT HEPARIN; NAPROXEN; PHENAZONE; PHYTOMENADIONE; POLYPROPYLENE; POTASSIUM CHLORIDE; SILICON DIOXIDE; TANOMASTAT; TESTOSTERONE; THEOPHYLLINE; TITANIUM DIOXIDE; VASOPRESSIN; VERAPAMIL;

ABSORPTION; ADSORPTION; CONTROLLED RELEASE FORMULATION; CRYSTALLIZATION; DECOLORIZATION; DRUG BIOAVAILABILITY; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG PURIFICATION; DRUG SOLUBILITY; DRUG STABILITY; DRUG TRANSPORT; MACROPOROSITY; MESOPOROSITY; MICROPOROSITY; POROSITY; REPRODUCIBILITY; REVIEW; SURFACE PROPERTY; SUSTAINED RELEASE FORMULATION;

EID: 77249111754     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: 10.4103/0250-474X.59540     Document Type: Review

References (52)

1. Wang C, He C, Tong Z, Liu X, Ren B, Zeng F. Combination of adsorption by porous CaCO3 microparticles and encapsulation by polyelectrolyte multilayer films for sustained drug delivery. Int J Pharm 2006;308:160-167
2. Li Z, Wen L, Shao L, Chen J. Fabrication of porous silica nanoparticles and their applications in release control. J Control Release 2004;98:245-254
3. Benita S, editor. Microencapsulation, Drugs and the Pharmaceutical Science. New York: Marcel Dekker; 2004.
4. Brigger I, Dubernet C, Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev 2002;54:631-651
5. Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 2005;4:145-160
6. Allen TM, Cullis PR. Drug delivery systems: Entering the main stream. Science 2004;303:1818-1822
7. Sher P, Insavle G, Porathnam S, Pawar AP. Low Density porous carrier drug adsorption and release study by response surface methodology using different solvents. Int J Pharm 2007;331:72-83.
8. Shivanand P, Sprockel OL. A controlled porosity drug delivery system. Int J Pharm 1998;167:83-96.
9. Sharma S, Sher P, Badve S, Atmaram PP. Adsorption of Meloxicam on porous calcium silicate: Characterisation and tablet formulation. AAPS Pharm Sci Tech 2005;6:E618-25.
10. Streubel A, Sipemann J, Bodmeier R. Floating matrix tablets based on low density foam powder: Effects of formulation and processing parameters on drug release. Eur J Pharm Sci 2003;18:37-45.
11. Yuasa H, Takashima Y, Kanaya Y. Studies on the development of intragastric floating and sustained release preparation: I: Application of calcium silicate as a floating carrier. Chem Pharm Bull (Tokyo) 1996;44:1361-1366
12. Strebuel A, Siepmann J, Bodmeier R. Floating microparticles based on low density foam powder. Int J Pharm 2002;241:279-292
13. Salis A, Sanjust E, Solinas V, Monduzzi M. Characterization of Accurel MP 1004 polypropylene powder and its use as a support for lipase immobilization. J Mol Cat B Enz 2003;24-25:75-82.
14. Byrne RS, Deasy PB. Use of commercial porous ceramic particles for sustained drug delivery. Int J Pharm 2002;246:61-73.
15. Song SW, Hidajat K, Kawi S. Functionalized SAB-15 material as carrier from controlled drug delivery: Influence of surface properties on matrix drug interactions. Langmuir 2005;21:9568-9575
16. Andersson J, Rosenhoim J, Areva S, Linden M. Influences of material characteristics on ibuprofen drug loading and release profiles from ordered micro- and mesoporous silica matrices. Chem Mater 2004;16:4160-4167
17. Faruk C. Scale effect on porosity and permeability: Kinetics model and correlation. Am Inst Chem Engg J 2001;47:271-287
18. Gurny R, Doelker E, Peppas NA. Modelling of sustained release of water soluble drugs from porous, hydrophobic polymers. Biomaterials 1981;3:27-32.
19. Gren T, Bjerre C, Camber O, Ragnarsson G. In vitro drug release from porous cellulose matrices. Int J Pharm 1996;141:53-62.
20. Charney C, Begu S, Tourne P, Nicole L, Lerner D, Devoisselle JM. Inclusion of ibuprofen in mesoporous template silica: Drug loading and release property. Eur J Pharm Biopharm 2003;57:533-540
21. Fletcher AJ. Porosity and sorption behaviour. http:// www.staff.ncl. ac.uk/a.j.fletcher /adsorption.htm (3rd Oct 2008)
22. Ayon AA, Cantu M, Chava K, Agrawal CM, Feldman MD, Johnson D, et al. Drug loading of Nanoporous TiO2 films. Biomed Mat 2006;1:L11-5.
23. http://www.mpi-halle.mpg.de/∼porous-m. (3rd Oct. 2008)
24. Ohta KM, Fuji M, Takeri T, Chikazawa M. Development of a simple method for the preparation of silica gel based controlled drug delivery system with high drug content. Eur J Pharm Sci 2005;26:87-96.
25. Li Z, Wen L, Shao L, Chen J. Fabrication of porous silica nanoparticles and their applications in release control. J Control Release 2004;98:245-254
26. Otsuka M, Tokumitsu K, Matsuda Y. Solid dosage form preparations from oily medicines and their drug release: Effect of degree of surface modification of silica gel on the drug release from phytonadione-loaded silica gel. J Control Release 2000;67:369-384
27. Salonen J, Laitinen L, Kaukonen AM, Tuura J, Bjorkqvist M, Heikkila T, et al. Mesoporous silicon microparticles for oral drug delivery: Loading and release of five model drugs. J Control Release 2005;108;362-374
28. Ito Y, Kusawake T, Ishida M, Tawa R, Shibata N, Takada K. Oral solid gentamicin preparation using emulsifier and adsorbent. J Control Release 2005;105:23-31.
29. Fisher KA, Huddersman KD, Taylor MJ. Comparison of micro and mesoporous inorganic materials in the uptake and release of the drug model fluorescein and its analogues. Chem Eur J 2003;9:5873-5878
30. Suzuki K, Yumura T, Tanaka Y, Akashi M. Thermo-responsive release from interpenetrating porous silica-poly (N-isopropylacrylamide) hybrid gels. J Control Release 2001;75:183-189
31. Kortesuo P, Ahola M, Kangas M, Leino T, Laakso S, Vuorilehto L et al. Alkyl-substituted silica gel as a carrier in the controlled release of dexmedetomidine. J Control Release 2001;76:227-238
32. Kim HW, Knowles JC, Kim HE. Hydroxyapatite/poly (epsiloncaprolactone) composite coatings on hydroxyapatite porous bone scaffold for drug delivery. Biomaterials 2004;25:1279-1287
33. El-Ghannam A, Ahmed K, Omran M. Nanoporous delivery system to treat osteomyelitis and regenerate bone: Gentamicin release kinetics and bactericidal effect. J Biomed Mater Res B: Appl Biomater 2005;73:277-284
34. Volodkin DV, Larionova NI, Sukhorukov GB. Protein encapsulation via porous CaCO3 microparticles templating. Biomacromolecules 2004;5:962-972
35. Moes AJ. Gastroretentive dosage forms. Crit Rev Ther Drug Carrier Syst 1993;10:143-195
36. Despande AA, Rhodes CT, Shah NH, Malick AW. Controlled release drug delivery systems for prolonged gastric residence: An overview. Drug Develop Ind Pharm 1996;22:531-539
37. Rouge N, Buri P, Doelker E. Drug absorption sites in the gastrointestinal tract and dosage forms for site specific drug delivery. Int J Pharm 1996;136:117-139
38. Hwang SJ, Park H, Park K. Gastric retentive drug delivery systems. Crit Rev Ther Drug Carrier Syst 1998;15:243-284
39. Singh BN, Kim KH. Floating drug delivery systems: An approach to oral controlled drug delivery via gastric retention. J Control Release 2000;63:235-259
40. Sepulveda P, Binner JG. Processing of cellular ceramics by foaming and in situ polymerization of organic monomers. J Eur Ceram Soc 2005;19:2059-2066
41. Choi SW, Kim JH. Design of surface-modified poly (D,L-lactide- coglycolide) nanoparticles for targeted drug delivery to bone. J Control Release 2007;122:24-30.
42. Shen S, Chow PC, Chen F, Tan RB. Submicron particles of SBA-15 modified with MgO as carriers for controlled drug delivery. Chem Pharm Bull 2007;55:985-991
43. Ito Y, Kusawake T, Prasad YV, Sugioka N, Sbhita N, Takada K. Preparation and evalution of oral solid gentamycin using emulsifier and adsorbent for in-vitro and in-vivo studies. Int J Pharm 2006;317:114-119
44. Patil P, Paradkar A. Porous polystyrene beads as carriers for selfemulsifying system containing loratadine. AAPS Pharm Sci Tech 2006;7:E1-7.
45. Fan YF, Wang YN, Fan YG, Ma FJB. Preparation of insulin nanoparticles and their encapsulation with biodegradable polyelectrolytes via the layer-by-layer adsorption. Int J Pharm 2006;324:158-167
46. Xia W, Chang J. Well-ordered mesoporous bioactive glasses (MBG): A promising bioactive drug delivery system. J Control Release 2006;110:522-530
47. Jette KK, Law D, Schmitt EA, Kwon GS. Preparation and drug loading of poly (Ethylene Glycol)-block-Poly(Caprolactone) micelles through the evaporation of a cosolvent Azeotrope. Pharm Res 2004;2:1184-1191
48. Patil S, Pancholi SS, Agrawal S, Agrawal GP. Surface modified mesoporous ceramics as delivery vehicle for haemoglobin. Drug Deliv 2004;1:193-199
49. Gupta MK, Tseng YC, Goldman D, Bogner RH. Hydrogen bonding with adsorbent during storage governs drug dissolution from soliddispersion granules. Pharm Res 2002;19:1663-1672
50. Queiroz AC, Santos JD, Monteiro FJ, Gibson IR, Knowles JC. Adsorption and release studies of sodium ampicillin from hydroxyapatite and glass-reinforced hydroxyapatite composites. Biomaterials 2001;22:1393-1400.
51. Tsung MJ, Burgess DJ. Preparation and characterization of gelatin surface modified PLGA microspheres. AAPS Pharm Sci Tech 2001;3:1-11.
52. Boer GJ, Kruisbrink J. A polymeric controlled drug delivery device for peptides based on a surface desorption/diffusion mechanism. Biomaterials 1987;8:265-274